The Asia Pacific TEO device market will expand rapidly over the forecast period, driven primarily by the large, underpenetrated patient pool in the region, increasing access to treatment due to improving health care systems, as well as the adoption of innovative products.
This Medtech 360 Report provides high-level market metrics for TEO devices in Asia Pacific, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 10-year period.
- Transcatheter Embolization And Occlusion Devices - Market Insights - Asia Pacific (Supplemental)
Author(s): Ashish Bhupal, MBA
Ashish Bhupal is a manager within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in clot management, vascular access, aortic repair, heart valve, structural heart, interventional oncology, peripheral vascular, neurovascular, and transcatheter embolization and occlusion device markets. Ashish holds a Bachelor's in Biotechnology and an MBA in Biotechnology Management from Amity University, as well as a Six Sigma Green Belt certification from The British Standards Institution.
Follow Ashish on Twitter: @Ashishb_DRG.